A Decade of Difference

Since Take Steps for Crohn's & Colitis was officially launched 10 years ago by the Crohn's & Colitis Foundation, patients, families, caregivers, and healthcare professionals across the country have been walking in support of those living with Crohn's disease and ulcerative colitis. We will celebrate our 10th anniversary recognizing everyone who strives every day to support the IBD community.

As a participant, you have made a difference over the past decade. You joined more than 300,000 others to raise awareness of these diseases and raised more than $85 million to support important research efforts and over $600, 000 right here in Jacksonville and we hope to add $90,000 more to that total on April 14!

Over the past decade, we have made significant advancements - all steps toward our ultimate goal, to achieve a future free of Crohn's disease and ulcerative colitis.

  • 2008 - Through its Pediatric Network, the Foundation launches the Pediatric RISK Stratification Study, designed to predict which pediatric patients will likely develop severe, complicated disease within three to five years from the time of diagnosis.
  • 2011 - IBD Partners, an internet-based study collecting self-reported disease information from patients, is created to study the course of IBD and the impact of these diseases on everyday life. A parallel study of childhood IBD, IBD Partners Kids & Teens, is launched in 2013.
  • 2012 - The Foundation’s Genetics Initiative is formed, allowing the study of 215 genes, how they interact with the environment, gut bacteria/viruses, and each other and prioritizing those genes that are most targetable by new therapies.
  • 2015 - The Foundation establishes IBD Qorus to improve the quality of IBD care delivered across the country through a standardized approach to care and actively engaging the patients as partners in their care.
  • 2016 - Launches Cost of IBD and Environmental Triggers initiatives.
  • 2017 - Results from the Foundation’s pediatric RISK Stratification Study identify predictors of disease course and severity in pediatric Crohn’s patients.

Thank you to our National Platinum Sponsor:

Thank you to our local sponsors